'Key Learnings from the Coronavirus Challenge and innovating for a sustainable future' Webinar

Overview

Since the first outbreak of the Coronavirus (COVID-19) in Wuhan, China, the epidemic has been spreading globally, causing uncertainty and crisis to the economy, business and people’s everyday life around the world. After fighting with COVID-19 for four months, China already has some creative practices to deal with the crisis. While the UK is getting impacted recently, UK companies are actively looking for ways to work through the situation. By bringing UK and China together, we can share creative ways of getting through the crisis and get better prepared for new opportunities after COVID-19

Objectives:

  1. Analyze COVID-19 situation and its impact on life science industry and companies
  2. Share the strategies and practices of how to keep business operation as usual and prepare for new business opportunities under COVID-19
  3. Explore new China expansion opportunities in the post COVID-19

 

This webinar is co-organised by:

BIA Logo - Colour (Large).png AZ logo.png I Campus Logo.jpg

 

Speakers

PANEL 1: Leading your business through the Coronavirus

10:00am – 10:50am
 

Companies have a series of problems to deal with, faced with the uncertainties and crisis of the coronavirus. What are the impacts of the Coronavirus on life science industry? How to work through the situation and keep business operation? How should companies recognize new opportunities and be prepared for them? We brought together senior leaders from the life science industry in both UK and China, to talk about these common questions from the macro-industry, business practice and academic perspectives, helping companies deal with the coronavirus crisis successfully

 

Moderator:

 

Tina Xu

Tina Xu

VP of AstraZeneca China, Head of Digital and Commercial Innovation, AstraZeneca China

 

Panellists:

 

 Steve Bates OBE

Steve Bates OBE

Chief Executive Officer

Leon Wang

Leon Wang

Executive Vice President, International and China President, AstraZeneca

Christian Hogg

Christian Hogg

CEO, Hutchison China MediTech (Chi-Med)

Dr. Zhi Hong

Dr. Zhi Hong

Co-founder and CEO, Brii Biosciences

 

PANEL 2: Embracing China opportunities in the post Coronavirus era

10:50am – 11:30am


The Coronavirus brought crisis as well as opportunities. China, as the 2nd largest pharma market in the world, is releasing huge amount of unmet patient needs in the outbreak. At the same time, we recognized opportunities we never saw before for life science innovations, including the transformation for medical system and the encouragement for overseas innovation. We brought leaders from the government, ecosystem and investment, to share new perspectives of China business expansion opportunities for UK and other overseas companies

 

Moderator:

 

Qionger He

Qionger He

Head of Pharma, Department for International Trade, British Consulate-General Shanghai

 

Panellists:

 

Yaguang Gao

Yaguang Gao

Deputy Mayor of Wuxi

Xiaohong Zhu

Xiaohong Zhu

Deputy Director of Wuxi New District

Dr. Xiaoping Ye

Dr. Xiaoping Ye

Founder and Chairman of Tigermed, Tigermed

Tina Xu

Tina Xu

VP of AstraZeneca China, Head of Digital and Commercial Innovation, AstraZeneca China

Rongrong Guo

Rongrong Guo

Executive GM, Investment Banking Department, CICC

Agenda

Time

Agenda

10:00 – 10:05 (UK) / 17:00 – 17:05 (China)

Opening

10:05 – 10:50 (UK) / 17:05 – 17:50 (China)

Panel 1 – Leading Your Business Through the Coronavirus

10:50 – 11:30 (UK) / 17:50 – 18:30 (China)

Panel 2 – Embracing China opportunities in the post Coronavirus era

How to register

Registration is by invitation only. 

If you are interested in attending or sponsoring, please email Jane Wall 

Jane Wall

Jane Wall

Managing Director


If you are interested in becoming a BIA member please email Michael McGivern

Michael McGivern

Michael McGivern

Associate Director, Membership & Business Development